This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2005-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2011
Title: **Susan J Kirst: Innovator in Nucleic Acid Modulation**
Introduction
Susan J Kirst is a notable inventor based in Brookline, Massachusetts, USA. She has made significant contributions to the field of biotechnology through her innovative research and development. With a total of two patents granted, her work focuses predominantly on methods of modulating nucleic acids and proteins, which have therapeutic applications.
Latest Patents
Susan's latest patents include groundbreaking inventions related to "Methods of Modulating the Activity of TANGO332." This invention enhances the understanding and usability of isolated nucleic acids that encode various proteins, which have diagnostic, preventive, and therapeutic uses. Specifically, her innovations allow for the diagnosis and treatment of various human and animal disorders. The patents also describe antisense nucleic acid molecules, expression vectors, host cells containing these vectors, and non-human transgenic animals utilized in her research. Additionally, they encompass isolated polypeptides, fusion polypeptides, antigenic peptides, and antibodies. The diagnostic, screening, and therapeutic methods explored in these patents highlight the potential for modifying cellular processes through newly developed compositions.
Career Highlights
Susan J Kirst currently works at Millennium Pharmaceuticals Limited, where her research focuses on advancing biotechnological applications that impact human health. Her innovative spirit and expertise in genetic modulation position her as a significant contributor to her field.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues, including Douglas A Holtzman and Christopher C Fraser. These partnerships emphasize the collaborative nature of research in biotechnology and highlight the importance of teamwork in driving innovation.
Conclusion
In summary, Susan J Kirst is an influential inventor whose work in the biotechnology sector demonstrates the power of isolated nucleic acids and proteins in treating various disorders. Her contributions through her patents are essential in furthering medical science and expanding the capabilities of therapeutic applications. Her career at Millennium Pharmaceuticals Limited and collaborations with fellow researchers underscore her commitment to innovation and improving human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile